Celldex Therapeutics (CLDX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 03-2021 | 12-2020 | 09-2020 | 06-2020 | 03-2020 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 69,313 | 43,836 | 18,151 | 68,027 | 22,724 |
| Marketable Securities | 106,770 | 150,586 | 181,443 | 138,888 | 30,998 |
| Receivables | 1,828 | 1,802 | 838 | 329 | 1,108 |
| TOTAL | $181,499 | $197,843 | $202,925 | $208,992 | $55,918 |
| Non-Current Assets | |||||
| PPE Net | 3,747 | 3,815 | 3,813 | 4,044 | 4,116 |
| Intangibles | 30,690 | 30,690 | 45,190 | 45,190 | 48,690 |
| Other Non-Current Assets | 3,129 | 3,490 | 3,842 | 3,175 | 3,780 |
| TOTAL | $37,566 | $37,995 | $52,845 | $52,409 | $56,586 |
| Total Assets | $219,065 | $235,838 | $255,770 | $261,401 | $112,504 |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | N/A | N/A | 2,362 | N/A | N/A |
| Accounts payable and accrued liabilities | 997 | 1,048 | 568 | 950 | 1,609 |
| Accrued Expenses | 7,023 | 8,459 | 8,007 | 6,467 | 5,648 |
| Other current liabilities | 7,585 | 3,372 | N/A | 2,104 | 1,993 |
| TOTAL | $16,977 | $14,206 | $12,200 | $10,841 | $10,932 |
| Non-Current Liabilities | |||||
| Other Non-Current Liabilities | 7,922 | 12,275 | 13,595 | 12,116 | 17,869 |
| TOTAL | $7,922 | $12,275 | $13,595 | $12,116 | $17,869 |
| Total Liabilities | $24,899 | $26,481 | $25,795 | $22,957 | $28,801 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 39,615 | 39,615 | 39,567 | 39,126 | 18,938 |
| Common Shares | 40 | 40 | 40 | 39 | 18 |
| Retained earnings | -1,089,634 | -1,073,096 | -1,051,196 | -1,036,972 | -1,025,941 |
| Other shareholders' equity | 2,587 | 2,589 | 2,608 | 2,594 | 2,597 |
| TOTAL | $194,166 | $209,357 | $229,975 | $238,444 | $83,703 |
| Total Liabilities And Equity | $219,065 | $235,838 | $255,770 | $261,401 | $112,504 |